Phase 2 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been formally diagnosed with schizophrenia according to standard psychiatric diagnostic guidelines (DSM-5-TR).
- People whose schizophrenia symptoms are in remission — meaning eight specific symptoms (such as hallucinations, delusions, and social withdrawal) have been rated as mild or below on a standard assessment scale for at least 6 months, and whose overall symptom score on that scale is 59 or lower at the start of the trial.
- People who are in good physical health and whose routine blood test results are not considered medically significant.
- People who have been taking the same dose of antipsychotic medication (not including clozapine) for at least 6 months, and who are able to keep that same dose unchanged for the full 12-week study period.
- People with enough education to communicate clearly and complete the study assessments.
- People who agree to take part and sign a written consent form.
Who may not be able to join:
- People who have a diagnosis of intellectual disability or a substance use disorder (including alcohol) according to DSM-5-TR guidelines.
- People with a history of epilepsy, significant head injury, or serious medical or neurological conditions (other than schizophrenia) that could affect the study.
- People who are pregnant or breastfeeding.
- People who would be unable to follow the study procedures as required.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 886 4 22052121
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change of cognitive function composite
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.